I'm curious as to what value you seem to think exists for big pharma to buy Amarin? There's no patent and there's already generics in the marketplace! Even if the generic label only includes the Trig reduction aspect we all know that CVRR scripts will be filled with generic anyway. I just don't understand why some people still think a buyout is an option? There's been no rumors on wall street about a buyout in a long time. I'm still working and still interviewing.